Trial intelligence / Profile preview

Lifitegrast in Contact Lens Discomfort

NCT03686878Phase 4Completed

Sponsor
EV Clinical Trials
Start
Dec 2016
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lifitegrast in Contact lens discomfort (CLD), sponsored by EV Clinical Trials. Started Dec 2016; status: completed.

02

Drugs

lifitegrast
03

Conditions

Contact lens discomfort (CLD)

Beyond the preview

Go deeper on NCT03686878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03686878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call